Sun, Mar 18, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing Weekly

Review of hedge fund launches, closures, trends, regulatory and legal events - week 16

Saturday, April 24, 2010

Benedicte Gravrand, Opalesque London:

Last week, we heard of fund launches from (new London-based FoHFs) Hilltop (All Weather); GAM (Ucits emerging markets); Strategic Investing (L/S mutual); Farema Capital (L/S); Artemis (FoHFs); Cheung Capital (gaming); Thesis (absolute return mutual); OM IM (global); Plural Capital (3 x offshore); Geribá Investments (maiden); Schroer Capital (healthcare); and Salus Alpha (special sits).

All EDHEC hedge fund Indicesexcept for Short Selling were positive in March, Emerging Markets (+4.48%) being the top performer; and the Scotia Capital Canadian hedge fund index was up 1.78%.

HFR said that the top hedge fund firms are assuming leadership in the industry recovery and that total AuM now stand at $1.67tn; Eurekahedge reported that hedge funds attracted net inflows of $2.83bn in March (its global hedge fund index is up 2.48% (est.), 2.14% YTD); and Credit Suisse found that the hedge fund industry had recovered 92% of financial crisis losses, as cautious optimism takes hold. Gottex’s assets slipped to $7.9bn in Q1 on asset-based wind-down and BlueBay’s assets rose 7.9%.

Hedge fund manager Gerard Griffin wound down his once $2.75bn fund; he and his partner Gerald Lucaussy joined GLG Partners, who said they will bolster its in-house expertise ahead of an expected surge in merger activity; Cairn Capital took over the management of Credaris’ Eur17m L/S fund; it was said that hedge fund clones had done relatively well during the crisis; Moore Capital is searching for longer-term investors after $5bn redemptions during the crisi......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t